Biosimilars
0
FDA Calls for Public Input
0

FDA has announced a public meeting and request for comment on proposed recommendations for the next reauthorization of the Biosimilar User Fee Act (BsUFA) ...

Show next
Som2ny Network
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart